People on the Move Hutchinson, Kuraray, Neste, Gilead, Nova and Mitsubishi Chemical Announce Changes to Management
Important management decisions have been made in the past few days at Total, Kuraray, Neste, Gilead, Nova and Mitsubishi Chemical. PROCESS worldwide summarizes the changes in company leadership for you.
Würzburg/Germany — Hélène Moreau-Leroy, 56, has been appointed Chairman and Chief Executive Officer of Hutchinson, succeeding Jacques Maigné. After graduating from the Insa grande école in Lyon and obtaining an MBA in international business from the University of New England in Australia, Moreau-Leroy began her career as Design Office Manager and then International Production and Purchasing Manager at the major industrial groups Thomson and Alstom.
She joined Safran's Purchasing Department in 2003, before moving to its subsidiary Safran Landing Systems, supplier aircraft landing and braking systems, first as Head of Supply Chain Development in emerging countries, then Director of the Airbus and European Programs Business Unit and finally Program Director. In 2013, she joined Safran's Executive Committee as Chief Executive Officer of Safran Transmission Systems, a division specialized in the design and manufacture of power transmissions for the aerospace and space industries, and in 2018 she oversaw the integration of Zodiac Aerospace on its acquisition by the Group. Moreau-Leroy is also Lead Director of the Board of Directors of Arkema and a Knight of the French National Order of the Legion of Honor.
Jun Inoue Joins the Management of Kuraray Europe
Jun Inoue (55) is joining the management of Kuraray Europe (KEG) as co-managing director, alongside Dr. Matthias Gutweiler. Inoue will also be in charge of the Advanced Materials division. In addition to the speciality chemicals business, he will therefore be responsible for the Elastomer, Dental, Industry and Microfibres business units. He intends to drive forward the focus on high-performance materials in Germany and Europe. Priorities are materials with a strong sustainability profile and the establishment of innovative 5G technologies for production and service. Jun Inoue is an economics graduate and takes over from Naoya Uehara, who is moving to a new management role at Kuraray in Japan.
Inoue has extensive experience of high-performance materials and an excellent knowledge of Kuraray’s international business. An economics graduate, Jun Inoue has worked for speciality chemicals producer Kuraray for more than 30 years, including holding positions in Japan and the USA. Before his appointment to Germany, he made a significant contribution to Kuraray’s Elastomer business in various management roles. Most recently, he was responsible for this entire business as General Manager Elastomer. In Hattersheim, he is taking over from Naoya Uehara, who is moving to a new management role in the Kuraray Group at the company’s global headquarters in Tokyo, Japan.
New Members of the Neste Board of Directors' Committees
Following the Annual General Meeting, Neste's Board of Directors elected the members of its two committees. Matti Kähkönen was elected Chairman and Martina Flöel, Jean-Baptiste Renard and Johanna Söderström were elected members of the Human Resources and Remuneration Committee. Marco Wirén was elected Chairman and John Abbott, Sonat Burman-Olsson, Nick Elmslie and Jari Rosendal were elected members of the Audit Committee.
Gilead Sciences Appoints Executive Vice President, Research
Gilead Sciences has announced that Dr. Flavius Martin will join the company as Executive Vice President, Research, becoming a member of the company's senior leadership team reporting to Chairman and Chief Executive Officer Daniel O'Day. Dr Martin will assume responsibility for Gilead's research organisation from 12 April 2021. Bill Lee, PhD, is retiring after three decades with the company.
Dr. Martin brings to his new role extensive experience in leading research organisations, with particular expertise in oncology and inflammation. He comes to Gilead from Amgen, where he most recently served as vice president of research biology, leading research in oncology, inflammation and cardiometabolic disease. He was also site manager for Amgen South San Francisco. Prior to joining Amgen, Dr. Martin worked as a scientist and executive at Genentech.
Dr. Martin received his MD from the University of Medicine and Pharmacy Timisoara, Romania. He completed his postdoctoral training at the University of Alabama at Birmingham in the Department of Developmental and Clinical Immunology. He has published numerous papers on the role of immune cells in the development of inflammatory diseases and cancer and holds a number of patents related to his discoveries.
Dr. Lee joined Gilead in 1991. Over his 30-year career with the company, he has led research programmes in a variety of therapeutic areas and has advanced numerous therapies from early research into clinical development. His expertise contributed to drug discovery and the identification of external partnerships.
Nova Chemicals Appoints New Chairman
Chemical company Nova Chemicals has appointed Ahmed Yahia, Chief Executive Officer, Direct Investments at Mubadala Investment Company, as Chairman of the Board of Nova Chemicals. Yahia succeeds Musabbeh Al Kaabi, who was appointed Chief Executive Officer, UAE Investments at Mubadala as part of Mubadala's recent restructuring. Al Kaabi will remain on the company's board of directors. Yahia is CEO, Direct Investments at Mubadala, with oversight of the energy, chemicals, technology, life sciences, consumer goods, industrials and financial services portfolios. Prior to joining Mubadala, he was a partner at McKinsey, where he was co-leader of the Principal Investor Practice and Managing Partner of the Abu Dhabi Practice. Prior to that, he was Marketing Manager at Procter & Gamble, where he led several flagship brands.
In addition, the following individuals have joined the Board: Saeed Al Mazrouei, Deputy Platform CEO, Direct Investments at Mubadala; Martin Edelman, Senior Of Counsel at Paul Hastings LLP; Alvin Teh, Executive Director, Chemicals at Mubadala.
Mitsubishi Chemical Hires New Head of Global Semiconductor Solution Division
Mitsubishi Chemical Corporation (MCC) has appointed Scott Jewler to its MC Chemical Solutions for Semiconductor (MCSS) division team. MCSS provides materials and services to the semiconductor industry. Jewler will lead the MCSS solutions division in the United States, while also being responsible for the precision cleaning, surface coating and treatment, and wafer reclaim services business globally. MCSS was founded in March 2019 and offers integrated solutions from a global portfolio of semiconductor products and services from a single source.
Jewler brings extensive experience from his work in the outsourced semiconductor assembly and test (OSAT) industry to the MCSS team. There, he held senior positions at three of the four largest OSAT companies in the world. He also holds seven US patents in the field of integrated circuit (IC) packaging. IC packaging surrounds the circuit material and ensures many years of reliable semiconductor use by protecting it from the elements and potential stressors.